InMed Pharmaceuticals
INM • NASDAQ • Stock Fundamentals
InMed Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric A. Adams Chem., with a market cap of $5.2M.
Market Cap$5.2M
Employees13.0
CEOEric A. Adams Chem.
CountryCanada
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
InMed Pharmaceuticals FAQ
Common questions about InMed Pharmaceuticals
InMed Pharmaceuticals (INM) has a market capitalization of $5.2M and trades on NASDAQ.
InMed Pharmaceuticals has approximately 13 employees.